In a letter that sent Earr this month, the Minister of Health Robert F. Kennedy Jr. and the Commissioner of Food and Drug Administration, Makary Makary, modified the agency, the Minister of Health Robert F. Kennedy Jr. and the Commissioner of Food and Drug Administration Risk assessment and reduction strategy Requirements.
The duo wrote that the review was stimulated by “recent studies that have brought about the security of Mifepriston as currently managed, but HHS” will carry out his own meditation “.
The update to states as HHS feels Printing of anti-abbreviation lawyers And legislators to limit themselves to Mifepriston.
The FDA initially appeared approved mifepriston in 2000 A number of changes made for ABORPTION up to seven weeks of pregnancy, but then in 2016 and 2021.
These changes included increasing this 10 weeks of templatesSo that the medication is sent to patients, reduces the dosage, the prescription of telemed physicians and other providers as doctors to prescribe air resistance.
The FDA has repeatedly determined that Mifepriston is Saffe and that a medication abdominal regime, the Mifepriston and a second medication, misoprostol, encompasses Safe and effective Alternative to surgical abortions.
But anti-abortive groups claim that the medication is dangerous.
It is not clear whether Kennedy and Makary will go so far to tell the medication from the market. However, they have given knowledge from a study by the conservative thinking tabent atmosphere and Public Policy Center (EPPC) as the reason to rethink the changes to the appointments managed by bidges.
The two health leaders wrote that “protection for women in relation to the administration of Mifepriston” was “significantly reduced”.
